ClinicalTrials.gg
CompletedNCT06307236Updated Nov 4, 2026

Dysmenorrhea of Emotional Freedom Techniques (EFT) and Its Effect on Perceived Stress Level

An interventional study of Emotional Freedom Techniques in Dysmenorrhea Primary, Stress and Emotional Freedom, sponsored by Kutahya Health Sciences University. Completed at 1 site in Turkey (Türkiye). Open to female participants aged 18 Years to 49 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-04.

Sponsored by Kutahya Health Sciences University · Not applicable, Interventional, and Supportive care

How we know

From the registry’s dates

  • Registered 3 months after the study started (first participant enrolled Nov 2023, registered Feb 2024).
Updated Nov 4, 2026Now CompletedFirst site in Turkey (Türkiye)+7 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
56
Allocation
Randomized
Ages
18 Years to 49 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-22

Among 81 studies in Dysmenorrhea with a site in Turkey — 19 open to participants now, 23 under way, none of them phase 3. Dysmenorrhea · Turkey.

Enrollment
44th of 72
56 · median 60
Started
2023
with 13 others
No phase
70 of 81
16 open now
Registered
34th of 81
by date

Among the 81 studies in Dysmenorrhea with a site in Turkey, this one is the 44th largest by enrollment of the 72 interventional ones that give a count, is one of 14 that started in 2023, is one of 70 with no phase, and was the 34th registered.

Dysmenorrhea

432 studies on the registry are indexed under Dysmenorrhea; 108 are open to participants now.

Browse Dysmenorrhea studies →

Open to participants now

19 of the 81 studies in Dysmenorrhea with a site in Turkey are open now. Recruiting first, the newest first:

14 more — sign in →

All 19 open studies →

A study can be open while its sites in Turkey have not opened yet or have stopped. Only those recruiting at a site in Turkey →

Who these studies take

Of the 59 Dysmenorrhea studies recruiting now, 7 (12%) set no upper age limit and 51 (86%) stop at 75 or younger; 12 take children under 18; 20 take healthy volunteers.

This study: 18 Years to 49 Years · female · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 81 studies in Dysmenorrhea with a site in Turkey, or all of them as a file.
02

Study summary

The aim of the study is to determine the effect of EFT application on the level of dysmenorrhea and stress perception in women with dysmenorrhea. For this purpose, EFT will be applied to women with dysmenorrhea with high stress perception assigned to the experimental and control groups, and their stress perceptions and dysmenorrhea levels will be re-evaluated after the application. Perceived Stress Scale (PSS) and Visual Analog Scale (VAS) will be used in the research.

Read the detailed description

Application of the experimental group The women in the experimental group will be informed about the function, click points and application of EFT through a written material. The EFT application will be explained practically by a certified researcher and the application steps will be followed. Women who underwent EFT will be contacted again within a week or two and asked how they feel and feedback will be received about whether the problem or problems during the first meeting still bother them. By asking women to show how they feel on the SUE scale, the EFT application will be repeated until the woman expresses positive emotions on the SUE scale. The number of EFT applications will be decided according to the woman's condition. After the EFT application is completed, the woman will be re-evaluated with VAS and PSS in the 1st and 2nd months. It will be recorded and reported as perceived stress when assessing The EFT practitioner researcher's certification is S.E.M. It is a certificate with a total scope of 50 hours, including face-to-face training, issued by the Academy considering International Education standards and criteria. The training was given by a trainer with a trainer certificate on EFT. The researcher, who has a nationally and internationally valid certificate, has prepared a guideline in parallel with the training he has received, received expert opinions on the guideline and will carry out its pilot application.

Application of the control group A meeting will be held with the women in the control group at the beginning of the research and information will be given about the study. The researcher will open a WhatsApp group for the women in the control group and follow them to eliminate their lack of information. Throughout the research, women in the control group will continue their routine coping habits regarding dysmenorrhea and perceived stress levels, and this group, like the experimental group, will be re-evaluated with VAS and PSS in the 1st and 2nd months of the research.

03

Conditions studied

  • Dysmenorrhea Primary
  • Stress
  • Emotional Freedom

Browse trials for

04

Who can participate

Ages eligible
18 Years to 49 Years
Sexes eligible
Female
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Must be between 18-49 years old and single,
  • Must be literate and willing to participate in the study,
  • There should be no wounds, scars or infections in the area where EFT will be applied.
  • The perceived stress level must be high and they must be experiencing dysmenorrhea

Exclusion criteria

Exclusion Criteria:

  • There should be no change in menstrual cycle in the last six months,
  • There must be no communication problems or illnesses that may prevent work.
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
56 participants (actual)

Study arms

  • Experimental
    Experimental

    Group to be applied EFT

    Behavioral: Emotional Freedom Techniques

  • No intervention
    Control

    No application will be made

Interventions

  • BehavioralEmotional Freedom Techniques

    Emotional Freedom Technique (EFT), which is included in the energy psychotherapy similar to the cognitive behavioral therapy method, is an easily applicable method that is used to relieve mental problems such as anxiety and stress and has positive results, which has just started to be used in the world and in our country. EFT can be applied safely to all ages and groups.

06

What researchers measure

Primary outcomes

  1. EFT application

    Perceived stress scale, VAS

    Time frame: 12 weeks

  2. Control

    Perceived stress scale, VAS

    Time frame: 12 weeks

07

Study locations

1 site
  • Kütahya Health Science University
    Kütahya, Kütahya 43000, Turkey (Türkiye)
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Nov 2023 to primary completion in Mar 2024, 4 months.

Of 179 non-industry interventional studies with no phase under Dysmenorrhea, half reached primary completion within 8 months of starting (the median), counting those still running; a quarter within 4 and three quarters within 16. This study's 4 months is below that.

Counting every sponsor, half of 189 studies reached it within 8 months; a quarter within 3 and three quarters within 17.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 4, 2026: start Dec 2023 → Nov 2023, primary completion Apr 2024 → Mar 2024 and completion Apr 2024 → Mar 2024.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Feb 27, 2024
First posted
Mar 12, 2024
StartActual
Nov 1, 2023was Dec 2023
Primary completionActual
Mar 1, 2024was Apr 2024
CompletionActual
Mar 1, 2024was Apr 2024
Last update
Nov 4, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Enrolling by invitation→Completed
changed Nov 4, 2026
Sites
1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
Show site
  • Kütahya Health Science University · Kütahya, Turkey (Türkiye)
Show 1 removed
  • Kütahya Health Science University · Kütahya, Turkey
Nov 4, 2026
Start date
Dec 15, 2023→Nov 1, 2023
Nov 4, 2026
Primary completion
Apr 15, 2024→Mar 1, 2024 (actual)
Nov 4, 2026
Study completion
Apr 15, 2024→Mar 1, 2024 (actual)
Nov 4, 2026
Show all 1 update
  1. Nov 4, 2026
    Enrolling by invitation→Completed
    1 site added, 1 site removed — first site in Turkey (Türkiye); no longer in Turkey
    Show site
    • Kütahya Health Science University · Kütahya, Turkey (Türkiye)
    Show 1 removed
    • Kütahya Health Science University · Kütahya, Turkey
    Start date Dec 15, 2023→Nov 1, 2023
    Primary completion Apr 15, 2024→Mar 1, 2024 (now actual)
    Study completion Apr 15, 2024→Mar 1, 2024 (now actual)
    + 1 other change: index terms

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT06307236
Responsible party
Elif TUGCE CITIL (assistant professor, Kutahya Health Sciences University) — Principal investigator
First posted
Mar 12, 2024
Start date
Nov 1, 2023
Primary completion
Mar 1, 2024
Completion
Mar 1, 2024
Last update
Nov 4, 2026

Study contacts

Elif Tuğçe ÇİTİL
principal investigator · Kütahya Health Science University

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Mar 2024. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion